Table 1

The expression levels of IDO1 and IDO2 in PBMCs.

ΔCt Controls

ΔCt Nonagenarians

RQ

p

IDO1

4.82

5.05

0.85

n.s.

IDO2

9.17

9.75

0.67

n.s.

No statistically significant differences were found in the expression levels of IDO1 or IDO2 in PBMCs between nonagenarians and young controls, despite the difference in the level of IDO enzyme activity in the plasma.

Marttila et al. Immunity & Ageing 2011 8:9   doi:10.1186/1742-4933-8-9